CGENCompugen Ltd.

$215M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$9M

Net Income

-$8M

EPS (Diluted)

$-0.14

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$51M

Total Liabilities

$18M

Stockholders' Equity

$33M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$10M	-100.0%
Gross Profit	$0	$10M	-100.0%
Operating Income	-$9M	$115,000	-7503.5%
Net Income	-$8M	$104,000	-8184.6%

CGEN Q1 2019 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena